CO₂ Solutions Wins Gold Leaf Award as Emerging Company of the Year

Oct. 17, 2017


Quebec City, October 17, 2017 – CO₂ Solutions Inc. (or the “Corporation”) (TSX-V: CST) is pleased to announce that it has won the Gold Leaf Award for Emerging Company of the year in the agricultural and industrial sector.

On October 16, 2017, BIOTECanada announced the winners of its annual Gold Leaf Awards and, more specifically, that CO₂ Solutions Inc. had won the Emerging Company of the Year Award. Launched in 2001, the Gold Leaf awards are given annually to recognize both companies and individuals who have made significant contributions to the biotech industry in Canada. The Awards’ importance to the recipients and the industry more broadly has grown significantly over the years.

“We are very excited to receive this prize as it recognizes the cutting-edge aspect of our technology and confirms our progress to commercialization,” said Evan Price, President and Chief Executive Officer of CO₂ Solutions.

“BIOTECanada is proud to announce CO₂ Solutions as winner of a 2017 Gold Leaf Award for emerging agriculture/industrial company. One of the promises of biotechnology is that it can help reduce the environmental impact of traditional manufacturing and industrial processes in agriculture, forestry, and chemical production. It is this strength that establishes Canada’s biotech industry as a leader in developing the solutions to address global social and economic challenges emerging from population growth and a changing climate. CO₂ Solutions has developed an incredible technology for the enzymatic capture of CO₂ emissions from large sources such as coal-fired plants and aluminum refineries. The platform generates high-purity CO₂ ideal for utilization applications and reduces costs, which makes it attractive to businesses as they prepare for the Federal government’s promised implementation of a carbon tax in the near future,” indicated Andrew Casey, President and CEO BIOTECanada.

About BIOTECanada

BIOTECanada is the national industry association with more than 200 members located nationwide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors. In addition to providing significant health benefits for Canadians, the biotechnology industry has quickly become an essential part of the transformation of many traditional cornerstones of the Canadian economy including manufacturing, automotive, energy, aerospace and forestry industries.

About CO₂ Solutions Inc.

CO₂ Solutions is an innovator in the field of enzyme-enabled carbon capture and has been actively working to develop and commercialize the technology for stationary sources of carbon emissions. CO₂ Solutions’ technology lowers the cost barrier to Carbon Capture, Utilization and Sequestration (CCUS), positioning it as a viable CO₂ mitigation tool, as well as enabling industry to derive profitable new products from these emissions. CO₂ Solutions has built an extensive patent portfolio covering the use of carbonic anhydrase, or analogues thereof, for the efficient post-combustion capture of carbon dioxide with low‐energy aqueous solvents. Further information can be found at

CO₂ Solutions Forward-looking Statements

Certain statements in this news release may be forward-looking. These statements relate to future events or CO₂ Solutions’ future economic performance and reflect the current assumptions and expectations of management. Certain unknown factors may affect the events, economic performance and results of operation described herein. CO₂ Solutions undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable law.

Investor Relations and Media Contact:

CO₂ Solutions
Jérémie Lavoie
(418) 842-3456, ext. 223
[email protected]₂


Marc Lakmaaker
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

tel : 418.842.3456 fax : 418.842.1732
General information: [email protected]